5‐[3‐(2‐chloroethyl)‐1‐triazenyl]imidazole‐4‐carboxamide and a Possible Mechanism of Action of 5‐[3,3‐Bis(2‐chloroethyl)‐1‐triazenyl]imidazole‐4‐carboxamide

This publication has 10 references indexed in Scilit:

• Mechanism of action of 5-(3,3-dimethyl-1-triazeno)imidazole-4-caboxamide in mammalian cells in culture
  Biochemical Pharmacology, 1972
• Methylation of nucleic acids and urinary excretion of 14C-labeled 7-methylguanine by rats and man after administration of 4(5)-(3,3-Dimethyl-1-triazeno)-imidazole 5(4)-carboxomide
  Toxicology and Applied Pharmacology, 1971
• Metabolism of 4(5)-(3,3-dimethyl-1-triazeno)imidazole-5(4)-carboxamide to 4(5)-aminoimidazole-5(4)-carboxamide in man
  Biochemical Pharmacology, 1970
• Mechanism of carcinogenesis with 1-aryl-3,3-dialkyltriazenes—II in vitro-alkylation of guanosine, RNA and DNA with aryl-monoalkyltriazenes to form 7-alkylguanine
  Biochemical Pharmacology, 1970
• Elevated urinary excretion of 4-aminoimidazole-5-carboxamide in patients after intravenous injection of 4-(3, 3-dimethyl-1-triazeno) imidazole-5-carboxamide
  Life Sciences, 1969
• Mechanism of carcinogenesis with 1-Aryl-3,3-dialkyltriazenes. Enzymatic dealkylation by rat liver microsomal fraction in vitro
  Biochemical Pharmacology, 1969
• Single crystal studies of chemotherapeutic agents. I. Structure of 1-(2-chloroethyl)-3-(5-carbamoylimidazol-4-yl)-.DELTA.2-1,2,3-triazolinium chloride
  Journal of Medicinal Chemistry, 1969
• Synthesis and Properties of the Antileukemic Agent 5(or 4)-[3,3-Bis(2-chloroethyl)-1-triazeno]imidazole-4(or 5)-carboxamide
  Journal of Pharmaceutical Sciences, 1968
• Complete Inhibition of Mouse Leukaemia L1210 by 5(or 4)-[3,3-Mbis (2-Chloroethyl)-l-triazeno]imidazole-4(or 5)-carboxamide (NSC-82196)
  Nature, 1966
• Imidazoles. II. 5(or 4)-(Monosubstituted Triazeno)imidazole-4(or 5)-carboxamides¹
  Journal of Medicinal Chemistry, 1966